BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32085659)

  • 1. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.
    Dhanyamraju PK; Iyer S; Smink G; Bamme Y; Bhadauria P; Payne JL; Dovat E; Klink M; Ding Y
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.
    Wang H; Song C; Ding Y; Pan X; Ge Z; Tan BH; Gowda C; Sachdev M; Muthusami S; Ouyang H; Lai L; Francis OL; Morris CL; Abdel-Azim H; Dorsam G; Xiang M; Payne KJ; Dovat S
    J Biol Chem; 2016 Feb; 291(8):4004-18. PubMed ID: 26655717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein signaling and regulation of gene transcription in leukemia: role of the Casein Kinase II-Ikaros axis.
    Gowda CS; Song C; Ding Y; Kapadia M; Dovat S
    J Investig Med; 2016 Mar; 64(3):735-9. PubMed ID: 26912004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
    Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
    J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ikaros and tumor suppression in acute lymphoblastic leukemia.
    Payne KJ; Dovat S
    Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.
    Gowda C; Song C; Kapadia M; Payne JL; Hu T; Ding Y; Dovat S
    Adv Biol Regul; 2017 Jan; 63():71-80. PubMed ID: 27666503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.
    Dovat E; Song C; Hu T; Rahman MA; Dhanyamraju PK; Klink M; Bogush D; Soliman M; Kane S; McGrath M; Ding Y; Desai D; Sharma A; Gowda C
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.
    Song C; Gowda C; Pan X; Ding Y; Tong Y; Tan BH; Wang H; Muthusami S; Ge Z; Sachdev M; Amin SG; Desai D; Gowda K; Gowda R; Robertson GP; Schjerven H; Muschen M; Payne KJ; Dovat S
    Blood; 2015 Oct; 126(15):1813-22. PubMed ID: 26219304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia.
    Ge Z; Zhou X; Gu Y; Han Q; Li J; Chen B; Ge Q; Dovat E; Payne JL; Sun T; Song C; Dovat S
    Oncotarget; 2017 Jan; 8(5):8022-8034. PubMed ID: 28030830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.
    Payne JL; Song C; Ding Y; Dhanyamraju PK; Bamme Y; Schramm JW; Desai D; Sharma A; Gowda C; Dovat S
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Ikaros in B Cell Acute Lymphoblastic Leukemia].
    Zhang HY; Bai H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1194-8. PubMed ID: 26314472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.
    Song C; Ge Z; Ding Y; Tan BH; Desai D; Gowda K; Amin S; Gowda R; Robertson GP; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Gurel Z; Iyer S; Dhanyamraju PK; Xiang M; Kawasawa YI; Cury NM; Yunes JA; McGrath M; Schramm J; Su R; Yang Y; Zhao Z; Lyu X; Muschen M; Payne KJ; Gowda C; Dovat S
    Blood; 2020 Sep; 136(13):1520-1534. PubMed ID: 32396934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity.
    Ding Y; Zhang B; Payne JL; Song C; Ge Z; Gowda C; Iyer S; Dhanyamraju PK; Dorsam G; Reeves ME; Desai D; Huang S; Payne KJ; Yue F; Dovat S
    Leukemia; 2019 Nov; 33(11):2720-2731. PubMed ID: 31073152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
    Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
    Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?
    Conserva MR; Redavid I; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Parciante E; Coccaro N; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
    Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
    Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia.
    Hu Y; Zhang Z; Kashiwagi M; Yoshida T; Joshi I; Jena N; Somasundaram R; Emmanuel AO; Sigvardsson M; Fitamant J; El-Bardeesy N; Gounari F; Van Etten RA; Georgopoulos K
    Genes Dev; 2016 Sep; 30(17):1971-90. PubMed ID: 27664237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1
    Schjerven H; Ayongaba EF; Aghajanirefah A; McLaughlin J; Cheng D; Geng H; Boyd JR; Eggesbø LM; Lindeman I; Heath JL; Park E; Witte ON; Smale ST; Frietze S; Müschen M
    J Exp Med; 2017 Mar; 214(3):793-814. PubMed ID: 28190001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor Ikaros shapes the repertoire of notch target genes in T cells.
    Geimer Le Lay AS; Oravecz A; Mastio J; Jung C; Marchal P; Ebel C; Dembélé D; Jost B; Le Gras S; Thibault C; Borggrefe T; Kastner P; Chan S
    Sci Signal; 2014 Mar; 7(317):ra28. PubMed ID: 24643801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-specific function of Ikaros in human leukemia.
    Li Z; Song C; Ouyang H; Lai L; Payne KJ; Dovat S
    Pediatr Blood Cancer; 2012 Jul; 59(1):69-76. PubMed ID: 22106042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.